InvestorsHub Logo
Followers 13
Posts 2213
Boards Moderated 0
Alias Born 08/11/2017

Re: None

Thursday, 09/20/2018 8:56:50 PM

Thursday, September 20, 2018 8:56:50 PM

Post# of 334
Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset

https://www.otcmarkets.com/stock/XCUR/news/story?e&id=1175795
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XCUR News